THE ROLE OF P2 RECEPTORS, THEIR AGONISTS AND ANTAGONISTS, CD39 AND CD73 IN ONCOGENESIS

O.S. Mikhaylova1, I.S. Raginov1-4

1Kazan State Medicale University, Kazan

2Volga Region branch of N.N. Blokhin Russian Cancer Research Center, Kazan

3Kazan Federal University, Kazan

4Republican Clinical Hospital, Kazan

Mikhaylova Olga S. ― student of the Kazan State Medicale University

49 Butlerov St., Kazan, Russian Federation, 420012, tel. +7-937-578-68-11, e-mail: olyagirl97@mail.ru

Abstract. This reviews examines the effect of ATP and adenosine, which are fundamental components of the tumor environments, were they affect tumor growth, immune cell functions and tumor-host interaction in different ways. The studies addressing chemical compounds important for studying P2 receptors and also compounds with potential for cancer treatment are analyzed. Enzymes CD39 and CD73 related with the purinergic system have also been studied. They produced adenosine which leads to suppression of antitumor immune responses. These nucleotidases are the most attractive targets in the treatment of cancer.

Key words: P2 receptors, ATP, P2 receptors agonists and antagonists, CD39, CD73, cancer.